Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,961
  • Shares Outstanding, K 100,565
  • Annual Sales, $ 446,550 K
  • Annual Income, $ -15,550 K
  • EBIT $ -4 M
  • EBITDA $ 3 M
  • 60-Month Beta 1.40
  • Price/Sales 0.39
  • Price/Cash Flow N/A
  • Price/Book 3.86

Options Overview Details

View History
  • Implied Volatility 153.39% ( -111.97%)
  • Historical Volatility 61.02%
  • IV Percentile 85%
  • IV Rank 28.98%
  • IV High 497.53% on 07/12/24
  • IV Low 12.97% on 06/10/24
  • Put/Call Vol Ratio 0.09
  • Today's Volume 142
  • Volume Avg (30-Day) 132
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 6,365
  • Open Int (30-Day) 5,646

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.01
  • Low Estimate -0.02
  • Prior Year -0.10
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7000 unch
on 11/15/24
2.1550 -21.11%
on 11/08/24
-0.1700 (-9.09%)
since 10/15/24
3-Month
1.6900 +0.59%
on 09/25/24
2.4900 -31.73%
on 08/22/24
-0.4700 (-21.66%)
since 08/15/24
52-Week
1.4000 +21.43%
on 08/12/24
3.0500 -44.26%
on 12/27/23
-0.8400 (-33.07%)
since 11/15/23

Most Recent Stories

More News
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 1.7000 (-2.30%)
Accuray: Fiscal Q4 Earnings Snapshot

Accuray: Fiscal Q4 Earnings Snapshot

ARAY : 1.7000 (-2.30%)
This Penny Stock Insider Just Bought 100K Shares

This insider scooped up 100k shares after penny stock ARAY sold off last month.

ARAY : 1.7000 (-2.30%)
Accuray: Fiscal Q3 Earnings Snapshot

Accuray: Fiscal Q3 Earnings Snapshot

ARAY : 1.7000 (-2.30%)
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 1.7000 (-2.30%)
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.23 (-2.78%)
ONCY : 0.9800 (-2.97%)
ONC.TO : 1.38 (-2.13%)
DSNKY : 29.5900 (+0.87%)
GILD : 88.40 (-4.03%)
ARAY : 1.7000 (-2.30%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 63.23 (-2.78%)
ONCY : 0.9800 (-2.97%)
ONC.TO : 1.38 (-2.13%)
DSNKY : 29.5900 (+0.87%)
GILD : 88.40 (-4.03%)
ARAY : 1.7000 (-2.30%)
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 1.7000 (-2.30%)
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy...

ARAY : 1.7000 (-2.30%)
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenosâ„¢, for...

ARAY : 1.7000 (-2.30%)

Business Summary

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing...

See More

Key Turning Points

3rd Resistance Point 1.9167
2nd Resistance Point 1.8733
1st Resistance Point 1.7867
Last Price 1.7000
1st Support Level 1.6567
2nd Support Level 1.6133
3rd Support Level 1.5267

See More

52-Week High 3.0500
Fibonacci 61.8% 2.4197
Fibonacci 50% 2.2250
Fibonacci 38.2% 2.0303
Last Price 1.7000
52-Week Low 1.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar